BALÁŽOVÁ, Zuzana, Igor ČERNÝ and Petr VYSKOVSKY. Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity. CASE REPORTS IN ONCOLOGY. BASEL: KARGER, 2020, vol. 13, No 1, p. 431-435. ISSN 1662-6575. Available from: https://dx.doi.org/10.1159/000506829.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity
Authors BALÁŽOVÁ, Zuzana (703 Slovakia, guarantor, belonging to the institution), Igor ČERNÝ (203 Czech Republic, belonging to the institution) and Petr VYSKOVSKY (203 Czech Republic).
Edition CASE REPORTS IN ONCOLOGY, BASEL, KARGER, 2020, 1662-6575.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/20:00115981
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1159/000506829
UT WoS 000533875000071
Keywords in English Fluciclovine; Incidental uptake; Neuroendocrine tumour
Tags 14110216, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 15/7/2020 09:07.
Abstract
18F-fluciclovine is a PET radiopharmaceutical used for the detection of recurrent prostate cancer in adult men after primary curative treatment with suspicion of recurrence based on elevated prostate-specific antigen level. Several incidental uptakes of 18F-fluciclovine in other tumour types have been described in the literature so far - in breast cancer, hepatocellular carcinoma, and malignant melanoma. Our case report presents a patient with oncological duplicity (prostate gland carcinoma and newly diagnosed neuroendocrine tumour) and with accumulation of fluciclovine in pathologically proved neuroendocrine tumour, later imagined also by octreotide SPECT/CT. To our knowledge, this is the first case of fluciclovine accumulated in a neuroendocrine tumour described in the literature.
PrintDisplayed: 26/4/2024 09:00